What Regulators Say After extensive review, regulatory agencies have concluded: No confirmed causal link between GLP-1 medications and anger or aggression No black box warnings related to mood Continued monitoring is appropriate This reflects a balanced interpretation of available evidencenot dismissal of patient experiences, but also not overstating risk
Improvement in fibrosis 1 stage without worsening of NASH was achieved in 26% with 30 mg and in 27% with 44 mg, versus 7% with placebo (p = 0.009 and p = 0.008), and resolution of NASH without worsening of fibrosis in 23% with 30 mg, 26% with 44 mg, and 37% with 15 mg, versus 2% with placebo
Ans: Yes, but only after consulting with a skin specialist
CrossRef Advanced Machine-Assisted Liver Reconditioning in Critical Care Yaroslava Longhitano, Giorgia Caputo, Michela Colella Bisogno, Cristian Manuel Perez, Raymond Planinsic, Sabino Mosca, Roberto Balagna, Gabriele Savioli, Christian Zanza Journal of Intensive Care Medicine .2025;[Epub] CrossRef 14,837 View 545 Download 23 Web of Science Crossref Abstract PDF Liver transplantation (LT) is a life-saving treatment for patients with end-stage liver disease and hepatocellular carcinoma (HCC)